Kala Bio (KALA) EBT Margin (QoQ) (2019 - 2022)
Kala Bio (KALA) EBT Margin (QoQ) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -241,900.00 |
| Jun 30, 2022 | 106,233.00 |
| Mar 31, 2022 | 23,661.00 |
| Dec 31, 2021 | -171,571.00 |
| Sep 30, 2021 | 10,175.00 |
| Jun 30, 2021 | -7,078.00 |
| Mar 31, 2021 | 47,229.00 |
| Dec 31, 2020 | 68,092.00 |
| Sep 30, 2020 | 529,528.00 |
| Jun 30, 2020 | -519,693.00 |
| Mar 31, 2020 | -36,574.00 |
| Dec 31, 2019 | -10,143.00 |
| Sep 30, 2019 | -19,667.00 |
| Jun 30, 2019 | 29,120.00 |